Beaumont Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$274K Sell
3,308
-200
-6% -$16.6K 0.02% 312
2025
Q1
$285K Hold
3,508
0.02% 300
2024
Q4
$316K Buy
3,508
+36
+1% +$3.24K 0.02% 284
2024
Q3
$343K Buy
3,472
+23
+0.7% +$2.27K 0.03% 257
2024
Q2
$320K Sell
3,449
-353
-9% -$32.7K 0.03% 265
2024
Q1
$361K Sell
3,802
-55
-1% -$5.22K 0.03% 251
2023
Q4
$344K Hold
3,857
0.03% 243
2023
Q3
$282K Hold
3,857
0.03% 258
2023
Q2
$321K Hold
3,857
0.03% 258
2023
Q1
$294K Hold
3,857
0.03% 251
2022
Q4
$320K Sell
3,857
-2
-0.1% -$166 0.03% 237
2022
Q3
$306K Buy
3,859
+2
+0.1% +$159 0.03% 232
2022
Q2
$286K Buy
3,857
+75
+2% +$5.56K 0.03% 249
2022
Q1
$340K Sell
3,782
-425
-10% -$38.2K 0.03% 266
2021
Q4
$471K Hold
4,207
0.03% 219
2021
Q3
$529K Sell
4,207
-175
-4% -$22K 0.04% 193
2021
Q2
$593K Buy
4,382
+22
+0.5% +$2.98K 0.05% 187
2021
Q1
$591K Sell
4,360
-3
-0.1% -$407 0.05% 179
2020
Q4
$614K Buy
4,363
+1
+0% +$141 0.05% 177
2020
Q3
$486K Buy
4,362
+65
+2% +$7.24K 0.05% 198
2020
Q2
$481K Buy
4,297
+251
+6% +$28.1K 0.05% 182
2020
Q1
$313K Sell
4,046
-12
-0.3% -$928 0.04% 182
2019
Q4
$386K Hold
4,058
0.04% 201
2019
Q3
$309K Sell
4,058
-175
-4% -$13.3K 0.03% 214
2019
Q2
$371K Sell
4,233
-55
-1% -$4.82K 0.04% 175
2019
Q1
$388K Buy
+4,288
New +$388K 0.04% 168
2018
Q4
Sell
-3,003
Closed -$288K 239
2018
Q3
$288K Sell
3,003
-33,022
-92% -$3.17M 0.03% 189
2018
Q2
$3.43M Buy
36,025
+33,022
+1,100% +$3.14M 0.36% 59
2018
Q1
$263K Sell
3,003
-34,636
-92% -$3.03M 0.03% 178
2017
Q4
$3.19M Buy
+37,639
New +$3.19M 0.37% 62
2013
Q4
Sell
-14,736
Closed -$634K 168
2013
Q3
$634K Buy
+14,736
New +$634K 0.06% 98